AstraZeneca and the Royal Academy of Engineering today (6 Oct) announced a partnership to help drive the development of health tech solutions in Africa.
The joint venture aims to establish connections between African healthcare innovators and AstraZeneca’s A.Catalyst Network, the pharma giant’s new platform with more than 20 global health innovation hubs.
In 2014 the Royal Academy of Engineering...
Pharma giant AstraZeneca is providing a new platform for innovators to discuss health innovation insights through interactive founder roundtables.
The first of two virtual events last week, in collaboration with startup event organisers Slush, explored how innovation can help rebuild healthcare. It also highlighted how collaboration improve patient outcomes and address unmet needs.
New startups...
The pharma world is now looking to digital tools to help facilitate everything from patient adherence to decentralized clinical trials. AstraZeneca has been in the digital game for some time. The life science giant recently teamed up with health system Mass General Brigham to help create and clinically validate patient-centric digital health solutions.
The collaboration used the pharma company’s...
The decentralized research organization Care Access Research has teamed up with AstraZeneca to support the Phase III clinical trial for AZD7442, AstraZeneca’s long-acting monoclonal antibody combination for the potential prevention of COVID-19.
Using Care Access’s Mobile Sites On Demand, the two will develop, deploy and manage clinical research sites across the country to assess the safety and...
Global biopharmaceutical company, AstraZeneca has announced a partnership through its Emerging Markets Health Innovation Hubs programme, with India-based AI solution provider, Qure.ai.
The partnership aims to to integrate AI solutions for the early detection of lung cancer in patients across AstraZeneca’s Emerging Markets regions, covering Latin America, Asia and the Middle East & Africa.
WHY...
US tech giant NVIDIA has announced plans to build the UK’s most powerful supercomputer, to help healthcare researchers.
The Cambridge-1 supercomputer is expected to come online by the end of the year and is intended for artificial intelligence (AI) research into medical challenges, including those presented by COVID-19.
Speaking at his GPU Technology Conference keynote, NVIDIA founder and CEO,...
Artificial intelligence-enabled in vitro diagnostics company Renalytix AI announced today a research partnership with AstraZeneca to develop and launch medical strategies for cardiovascular, renal and metabolic diseases.
The first stage of the collaboration will use KidneyIntelX, an AI-enabled in vitro diagnostic platform that gathers patient data from electronic medical records to generate a...
Cardio-focused digital health company Eko has inked a deal with AstraZeneca in order for the two to work together to develop digital health-screening tools.
According to the companies, the pharm giant will be looking to employ Eko’s AI-enabled algorithms in developing early detection tools, as well as to use the tech in clinical trials.
WHY IT MATTERS
Heart disease accounts for roughly one in...
Digital respiratory health company Propeller Health has received 510(k) clearance for a sensor and app intended for use with AstraZeneca's Symbicort inhaler for asthma and COPD, the company announced today.
The tool – which, according to the agency, was submitted to the agency in September and greenlit in late March – was developed in a previously unannounced partnership with the Cambridge,...
MyHeritage, a genealogy and health DNA testing company, has teamed up with the Beijing Genomics Institute (BGI) to establish a COVID-19 testing lab in its home country of Israel, the Jerusalem Post reported on Saturday. The facility is aiming to open its doors by April 9 with a 10,000-tests-per-day capacity, and hopes to scale up to 20,000 per day shortly after.
“BGI will ship to Israel in the...
